CSF2 and complex regional pain syndrome: Moreover, an age-matched disease control cohort of CRPS/NP patients (n = 50) failed to harbor any statistically significant autoantibody responses against IFN-α, IFN-γ, GM-CSF or IL-6 (Fig. 1).